{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:16:14Z","timestamp":1793736974209,"version":"4.6.1"},"reference-count":52,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>To understand the impact of blood donor and product characteristics on platelet transfusion outcomes, we linked these variables with recipients of single-unit apheresis-derived platelet products between 1 June 2020 and 31 March 2022. We used multivariable logistic regression to examine associations between donor and product characteristics on posttransfusion platelet counts and 24-hour red blood cell (RBC) transfusion events in 2808 transfusion recipients who received \u22651 platelet transfusions (N = 8207 units). Posttransfusion platelet increments &amp;gt;20 \u00d7 109\/L and RBC transfusion within 24 hours occurred after 24.9% and 37.7% of platelet transfusion events, respectively. After multivariable adjustment, donor variables, including increasing body mass index (BMI), platelet unit concentration, and elevated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antibody levels, were associated with increased odds of recipient platelet increments of &amp;gt;20 \u00d7 109\/L; whereas pathogen reduction, storage in platelet additive solution (PAS), platelet splits, and platelet storage between 5 and 7 days were associated with reduced odds. In parallel, increasing donor BMI and elevated SARS-CoV-2 nucleocapsid antibody levels were associated with lower odds of 24-hour RBC transfusion events. In contrast, pathogen reduction and irradiation were associated with increased odds of RBC transfusion, whereas longer storage, storage in PAS, and platelet unit concentration and splits were not associated with changes in RBC transfusion events. In conclusion, blood donor and product characteristics are predictors of changes in platelet counts and RBC requirements after platelet transfusion. Future studies examining the impact of blood donor and product characteristics on platelet function could be used to optimize platelet transfusion practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018841","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:12:01Z","timestamp":1773925921000},"page":"2582-2591","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Associations of blood donor and product characteristics with platelet transfusion outcomes"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1063-6155","authenticated-orcid":false,"given":"Nareg H.","family":"Roubinian","sequence":"first","affiliation":[{"name":"1Kaiser Permanente Northern California Division of Research, Pleasanton, CA"},{"name":"2Vitalant Research Institute, San Francisco, CA"},{"name":"3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Plimier","sequence":"additional","affiliation":[{"name":"1Kaiser Permanente Northern California Division of Research, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-9974","authenticated-orcid":false,"given":"Kimberly A.","family":"Thomas","sequence":"additional","affiliation":[{"name":"4Vitalant Research Institute, Denver, CO"},{"name":"5Department of Pathology, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9008-9154","authenticated-orcid":false,"given":"Bryan R.","family":"Spencer","sequence":"additional","affiliation":[{"name":"6Scientific Affairs, American Red Cross, Dedham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Bravo","sequence":"additional","affiliation":[{"name":"7Vitalant, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"7Vitalant, Scottsdale, AZ"},{"name":"8Department of Hematology, Southern Illinois University, Springfield, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-0548","authenticated-orcid":false,"given":"Lisa","family":"Baumann Kreuziger","sequence":"additional","affiliation":[{"name":"9Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-9509","authenticated-orcid":false,"given":"Eldad A.","family":"Hod","sequence":"additional","affiliation":[{"name":"10Department of Pathology, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-366X","authenticated-orcid":false,"given":"Brian","family":"Custer","sequence":"additional","affiliation":[{"name":"2Vitalant Research Institute, San Francisco, CA"},{"name":"3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kleinman","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0526-2088","authenticated-orcid":false,"given":"Philip J.","family":"Norris","sequence":"additional","affiliation":[{"name":"2Vitalant Research Institute, San Francisco, CA"},{"name":"3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[{"name":"2Vitalant Research Institute, San Francisco, CA"},{"name":"3Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"4","key":"2026042809462967100_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.hoc.2007.06.010","article-title":"Platelet transfusion therapy","volume":"21","author":"Slichter","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"2026042809462967100_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"2026042809462967100_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/asheducation-2018.1.585","article-title":"TACO and TRALI: biology, risk factors, and prevention strategies","volume":"2018","author":"Roubinian","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"9","key":"2026042809462967100_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/trf.17507","article-title":"How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? Demonstrated with the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric V2V database protocol","volume":"63","author":"Birch","year":"2023","journal-title":"Transfusion"},{"issue":"13","key":"2026042809462967100_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.2019000773","article-title":"Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion","volume":"134","author":"Roubinian","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2026042809462967100_bib6","first-page":"216","article-title":"The impact of donor sex and age on stored platelet metabolism and post-transfusion recovery","volume":"19","author":"D'Alessandro","year":"2021","journal-title":"Blood Transfus"},{"issue":"5","key":"2026042809462967100_bib7","doi-asserted-by":"crossref","first-page":"103746","DOI":"10.1016\/j.transci.2023.103746","article-title":"Association of blood donor characteristics with in vitro platelet storage properties","volume":"62","author":"Kaur","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"9","key":"2026042809462967100_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/vox.13495","article-title":"The impact of donor biological variation on the quality and function of cold-stored platelets","volume":"118","author":"Lorusso","year":"2023","journal-title":"Vox Sang"},{"issue":"25","key":"2026042809462967100_bib9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2026042809462967100_bib10","doi-asserted-by":"crossref","first-page":"e152598","DOI":"10.1172\/jci.insight.152598","article-title":"Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness","volume":"7","author":"Roubinian","year":"2022","journal-title":"JCI Insight"},{"issue":"15","key":"2026042809462967100_bib11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/bloodadvances.2017004820","article-title":"Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study","volume":"1","author":"Kanias","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"2026042809462967100_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/trf.18140","article-title":"Red blood cell urate levels are linked to hemolysis in vitro and post-transfusion as a function of donor sex, population and genetic polymorphisms in SLC2A9 and ABCG2","volume":"65","author":"Key","year":"2025","journal-title":"Transfusion"},{"issue":"13","key":"2026042809462967100_bib13","doi-asserted-by":"crossref","first-page":"e146077","DOI":"10.1172\/JCI146077","article-title":"Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage","volume":"131","author":"Page","year":"2021","journal-title":"J Clin Invest"},{"issue":"10","key":"2026042809462967100_bib14","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCRESAHA.122.321930","article-title":"Platelets and SARS-CoV-2 during COVID-19: immunity, thrombosis, and beyond","volume":"132","author":"Sciaudone","year":"2023","journal-title":"Circ Res"},{"issue":"11","key":"2026042809462967100_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCRESAHA.122.321659","article-title":"Persisting platelet activation and hyperactivity in COVID-19 survivors","volume":"131","author":"Martins-Gon\u00e7alves","year":"2022","journal-title":"Circ Res"},{"issue":"3","key":"2026042809462967100_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/trf.18159","article-title":"Blood donor SARS-CoV-2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients","volume":"65","author":"Roubinian","year":"2025","journal-title":"Transfusion"},{"issue":"4","key":"2026042809462967100_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/vox.12443","article-title":"Effect of platelet storage time on platelet measurements: a systematic review and meta-analyses","volume":"111","author":"Caram-Deelder","year":"2016","journal-title":"Vox Sang"},{"issue":"4","key":"2026042809462967100_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/vox.12494","article-title":"Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses","volume":"112","author":"Kreuger","year":"2017","journal-title":"Vox Sang"},{"issue":"14","key":"2026042809462967100_bib19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"2026042809462967100_bib20","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3201\/eid3008.240659","article-title":"Detection of nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors","volume":"30","author":"Grebe","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"2026042809462967100_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid3105.250021","article-title":"Detection of SARS-CoV-2 reinfections using nucleocapsid antibody boosting","volume":"31","author":"Grebe","year":"2025","journal-title":"Emerg Infect Dis"},{"issue":"23","key":"2026042809462967100_bib22","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1182\/blood-2011-11-393165","article-title":"The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia","volume":"119","author":"Triulzi","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2026042809462967100_bib23","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2026042809462967100_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1467-789X.2002.00056.x","article-title":"Obesity, haemostasis and the fibrinolytic system","volume":"3","author":"Mertens","year":"2002","journal-title":"Obes Rev"},{"issue":"6","key":"2026042809462967100_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"10","key":"2026042809462967100_bib26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF03344054","article-title":"Coagulation and fibrinolysis abnormalities in obesity","volume":"25","author":"De Pergola","year":"2002","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2026042809462967100_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1440-1681.2011.05589.x","article-title":"Adipokines and thrombosis","volume":"38","author":"Sch\u00e4fer","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"2026042809462967100_bib28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/blood-2013-04-491688","article-title":"Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase\u2013signaling pathways","volume":"122","author":"Wraith","year":"2013","journal-title":"Blood"},{"issue":"17","key":"2026042809462967100_bib29","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2014-05-574491","article-title":"Oxidized LDL activates blood platelets through CD36\/NOX2\u2013mediated inhibition of the cGMP\/protein kinase G signaling cascade","volume":"125","author":"Magwenzi","year":"2015","journal-title":"Blood"},{"key":"2026042809462967100_bib52","doi-asserted-by":"crossref","first-page":"834153","DOI":"10.1155\/2008\/834153","article-title":"Platelet counts and platelet activation markers in obese subjects","volume":"2008","author":"Samocha-Bonet","year":"2008","journal-title":"Mediators Inflamm"},{"key":"2026042809462967100_bib30","doi-asserted-by":"crossref","first-page":"104765","DOI":"10.1016\/j.jcv.2021.104765","article-title":"Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection","volume":"136","author":"Van Elslande","year":"2021","journal-title":"J Clin Virol"},{"issue":"6","key":"2026042809462967100_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tem.2023.03.002","article-title":"Long COVID: pathophysiological factors and abnormalities of coagulation","volume":"34","author":"Turner","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"2026042809462967100_bib32","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.crimmu.2023.100058","article-title":"Acute to post-acute COVID-19 thromboinflammation persistence: mechanisms and potential consequences","volume":"4","author":"Martins-Gon\u00e7alves","year":"2023","journal-title":"Curr Res Immunol"},{"issue":"7","key":"2026042809462967100_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-022-04318-x","article-title":"Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19","volume":"79","author":"Zhu","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2026042809462967100_bib34","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1038\/s41467-023-40824-7","article-title":"CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis","volume":"14","author":"Tang","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"2026042809462967100_bib35","doi-asserted-by":"crossref","first-page":"e150101","DOI":"10.1172\/JCI150101","article-title":"Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein","volume":"132","author":"Li","year":"2022","journal-title":"J Clin Invest"},{"issue":"18","key":"2026042809462967100_bib36","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.3390\/ijms22189701","article-title":"Characterization and therapeutic use of extracellular vesicles derived from platelets","volume":"22","author":"Spakova","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026042809462967100_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/hematolrep15020024","article-title":"Risk of thrombosis during and after a SARS-CoV-2 infection: pathogenesis, diagnostic approach, and management","volume":"15","author":"Sutanto","year":"2023","journal-title":"Hematol Rep"},{"issue":"16","key":"2026042809462967100_bib38","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.3390\/ijms22168580","article-title":"Platelet-derived extracellular vesicles for regenerative medicine","volume":"22","author":"Antich-Rossell\u00f3","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026042809462967100_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/trf.16747","article-title":"Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: an updated view during a pandemic","volume":"62","author":"Escolar","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"2026042809462967100_bib40","doi-asserted-by":"crossref","first-page":"150875","DOI":"10.1016\/j.tmrv.2025.150875","article-title":"Platelet additive solutions and pathogen reduction impact on transfusion safety, patient management and platelet supply","volume":"39","author":"Andreu","year":"2025","journal-title":"Transfus Med Rev"},{"issue":"6","key":"2026042809462967100_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/pathogens11060639","article-title":"Efficacy and safety of pathogen-reduced platelets compared with standard apheresis platelets: a systematic review of RCTs","volume":"11","author":"Pati","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"2026042809462967100_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-018-2114-x","article-title":"Platelet storage duration and its clinical and transfusion outcomes: a systematic review","volume":"22","author":"Aubron","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"2026042809462967100_bib43","doi-asserted-by":"crossref","first-page":"2433750","DOI":"10.1080\/09537104.2024.2433750","article-title":"Platelet life cycle during aging: function, production and clearance","volume":"35","author":"Reusswig","year":"2024","journal-title":"Platelets"},{"issue":"4","key":"2026042809462967100_bib44","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jtha.2023.11.025","article-title":"Cold-stored platelet hemostatic capacity is maintained for three weeks of storage and associated with taurine metabolism","volume":"22","author":"Shea","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"suppl 3","key":"2026042809462967100_bib45","first-page":"S146","article-title":"Comparison of platelet quality and function across apheresis collection platforms","volume":"63","author":"Thomas","year":"2023","journal-title":"Transfusion"},{"key":"2026042809462967100_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.11604\/pamj.2017.27.226.12116","article-title":"Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response","volume":"27","author":"Thuku","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"6","key":"2026042809462967100_bib47","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3324\/haematol.2022.282131","article-title":"How different are blood platelets from women or men, and young or elderly people?","volume":"108","author":"De Gaetano","year":"2023","journal-title":"Haematologica"},{"issue":"7","key":"2026042809462967100_bib48","doi-asserted-by":"crossref","first-page":"e2523674","DOI":"10.1001\/jamanetworkopen.2025.23674","article-title":"Sex differences in risk of adverse liver events in patients with cirrhosis","volume":"8","author":"Shi","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2026042809462967100_bib49","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/trf.18017","article-title":"Spike and nucleocapsid antibody dynamics following SARS-CoV-2 infection and vaccination: implications for sourcing COVID-19 convalescent plasma from routinely collected blood donations","volume":"64","author":"Clara Di Germanio","year":"2024","journal-title":"Transfusion"},{"issue":"5","key":"2026042809462967100_bib50","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-12-4443","article-title":"Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial","volume":"104","author":"McCullough","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2026042809462967100_bib51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jamaoncol.2017.5123","article-title":"Comparison of the hemostatic efficacy of pathogen-reduced platelets vs untreated platelets in patients with thrombocytopenia and malignant hematologic diseases: a randomized clinical trial","volume":"4","author":"Garban","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2582\/2513777\/blooda_adv-2025-018841-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2582\/2513777\/blooda_adv-2025-018841-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:46:48Z","timestamp":1777384008000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2582\/566139\/Associations-of-blood-donor-and-product"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018841","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,15]]}}}